Ebola Vaccine Trial Launches in DR Congo Outbreak Zone
Health workers in DR Congo have begun testing whether a vaccine designed for a different Ebola strain can protect against the current outbreak.
Clinical AI, drug discovery, devices, and regulatory approvals.
Health workers in DR Congo have begun testing whether a vaccine designed for a different Ebola strain can protect against the current outbreak.
The Trump administration's plan to bring most-favored-nation pricing to Medicaid has drawn participation requests from every state, according to the White House.
A new survey shows parents overwhelmingly believe the advantages of organized youth sports outweigh the harms for both themselves and their children.
The new layoff tracker shows major biotech employers still shedding staff in 2026, with Novo Nordisk making deep cuts and Sionna dramatically reducing headcount.
The new initiative aims to build an end-to-end system linking autism risk-factor identification, patient interventions, and clinical research.
A new analysis finds that many seniors with dementia or other cognitive conditions are prescribed medications that can worsen their health and lead to emergency visits.
First clinical trial tests activated regulatory T cells from healthy donors to prevent graft-versus-host disease in stem cell transplant patients.
A new opinion piece argues that the rise of physician-led political activism risks eroding patient trust and repeats historical mistakes in medicine.
A new study links irregular and persistently elevated cortisol patterns in saliva to cognitive decline over an 11-year period, with notable differences for Black participants.
A new device could make post-prostatectomy incontinence easier to manage by allowing men to control an artificial urinary sphincter remotely.
Two years after the Change Healthcare cyberattack, the industry has yet to fix the redundancy problem in its claims infrastructure.
A structural mismatch keeps eligible patients from discovering existing studies, and the fix is a structural one.
A large population study indicates that better thinking ability in youth is associated with reduced dementia risk decades later, though the relationship is not fully understood.
A new report identifies widely used preservatives associated with higher rates of high blood pressure and heart disease.
Two leading radiopharmaceutical companies are joining forces just as one of them absorbs a surprise regulatory setback.
A comprehensive research review suggests that tailored fall-prevention programs for older adults do not reduce how often falls occur.
The $600 million round, led by Vitruvian Partners, signals strong investor confidence in technology for employer-sponsored health benefits.
A Marine Corps veteran and advocate pressed the FDA to consider psychedelic treatments for severe mental health conditions, as reported by MedPage Today.